Joseph S. Redman

414 total citations
11 papers, 303 citations indexed

About

Joseph S. Redman is a scholar working on Epidemiology, Virology and Infectious Diseases. According to data from OpenAlex, Joseph S. Redman has authored 11 papers receiving a total of 303 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Epidemiology, 5 papers in Virology and 4 papers in Infectious Diseases. Recurrent topics in Joseph S. Redman's work include HIV Research and Treatment (5 papers), Liver Disease Diagnosis and Treatment (4 papers) and HIV/AIDS drug development and treatment (4 papers). Joseph S. Redman is often cited by papers focused on HIV Research and Treatment (5 papers), Liver Disease Diagnosis and Treatment (4 papers) and HIV/AIDS drug development and treatment (4 papers). Joseph S. Redman collaborates with scholars based in United States. Joseph S. Redman's co-authors include James N. Francis, Michael S. Kay, Matthew T. Weinstock, Debra M. Eckert, Brett D. Welch, Jacqueline D. Reeves, Yolanda Lie, Frank G. Whitby, Michael J. Root and Christopher P. Hill and has published in prestigious journals such as Gastroenterology, Journal of Virology and Biopolymers.

In The Last Decade

Joseph S. Redman

11 papers receiving 298 citations

Peers

Joseph S. Redman

VIROL

RNMI

EPIDE

Reshma Autar Netherlands

Ema T. Crooks United States

Isaac Zentner United States

Kazuki Izumi Japan

David Easterhoff United States

Jérôme Deval United States

Jared Lindenberger United States

Kara Anasti United States

Wilton B. Williams United States

Bridgette J. Connell France

Reshma Autar Netherlands

Joseph S. Redman

116 ×0.7

77 ×0.9

VIROL

117 ×1.4

17 ×0.3

RNMI

46 ×0.8

EPIDE

Citations per year, relative to Joseph S. Redman Joseph S. Redman (= 1×) peers Reshma Autar

Countries citing papers authored by Joseph S. Redman

Since Specialization

Citations

This map shows the geographic impact of Joseph S. Redman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph S. Redman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph S. Redman more than expected).

Fields of papers citing papers by Joseph S. Redman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph S. Redman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph S. Redman. The network helps show where Joseph S. Redman may publish in the future.

Co-authorship network of co-authors of Joseph S. Redman

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph S. Redman. A scholar is included among the top collaborators of Joseph S. Redman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph S. Redman. Joseph S. Redman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Danford, Christopher J., et al.. (2021). Hepatitis C-positive liver transplantation: outcomes and current practice. Current Opinion in Organ Transplantation. 26(2). 115–120. 1 indexed citations

Redman, Joseph S., et al.. (2021). Implications of pre-transplant sarcopenia and frailty in patients with non-alcoholic steatohepatitis and alcoholic liver disease. Translational Gastroenterology and Hepatology. 7. 29–29. 8 indexed citations

Redman, Joseph S., James B. Wade, HoChong Gilles, et al.. (2020). Training of hepatology providers improves the screening and resultant interventions for alcohol use disorder. Liver International. 40(9). 2090–2094. 10 indexed citations

Redman, Joseph S. & Richard K. Sterling. (2020). Non-invasive Assessment of Liver Fibrosis. Current Treatment Options in Gastroenterology. 18(2). 255–269. 2 indexed citations

Redman, Joseph S., James N. Francis, Robert Marquardt, et al.. (2018). Pharmacokinetic and Chemical Synthesis Optimization of a Potent d-Peptide HIV Entry Inhibitor Suitable for Extended-Release Delivery. Molecular Pharmaceutics. 15(3). 1169–1179. 14 indexed citations

Redman, Joseph S., Yamini Natarajan, Jason K. Hou, et al.. (2017). Accurate Identification of Fatty Liver Disease in Data Warehouse Utilizing Natural Language Processing. Digestive Diseases and Sciences. 62(10). 2713–2718. 27 indexed citations

Redman, Joseph S., Yamini Natarajan, Jingqi Wang, et al.. (2017). Utilizing Natural Language Processing (NLP) to Accurately Identify Fatty Liver Disease. Gastroenterology. 152(5). S1115–S1115. 3 indexed citations

Welch, Brett D., James N. Francis, Joseph S. Redman, et al.. (2013). Design of a Potent D-Peptide HIV-1 Entry Inhibitor with a Strong Barrier to Resistance. OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information). 12 indexed citations

Weinstock, Matthew T., James N. Francis, Joseph S. Redman, & Michael S. Kay. (2012). Protease‐resistant peptide design—empowering nature's fragile warriors against HIV. Biopolymers. 98(5). 431–442. 68 indexed citations

10.

Francis, James N., Joseph S. Redman, Debra M. Eckert, & Michael S. Kay. (2012). Design of a Modular Tetrameric Scaffold for the Synthesis of Membrane-Localized d-Peptide Inhibitors of HIV-1 Entry. Bioconjugate Chemistry. 23(6). 1252–1258. 21 indexed citations

11.

Welch, Brett D., James N. Francis, Joseph S. Redman, et al.. (2010). Design of a Potentd-Peptide HIV-1 Entry Inhibitor with a Strong Barrier to Resistance. Journal of Virology. 84(21). 11235–11244. 137 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact